menu

ReachMD

Be part of the knowledge.
Register

We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?

Register for free

JUPITER Study Shows Statins Help Even If Cholesterol Is Normal

ReachMD Healthcare Image
Restart
Resume
Choose a format
Media formats available:
Completing the pre-test is required to access this content.
Completing the pre-survey is required to view this content.
Details
Presenters
Comments
  • Overview

    According to a new study published in the New England Journal of Medicine, men and women who have normal cholesterol levels but signs of inflammation in the blood vessels (high levels of C-reactive protein) can cut the risk of heart attack or stroke in half.  Dr. Paul Ridker, author of the study, discusses the scope and findings of the study with host Dr. Larry Kaskel as well as the controversial implications of the study. Dr. Ridker explains the remarkable correlations between high-sensitivity C-reactive protein and cardiovascular disease, and reviews the number needed treat as compared with the use of statins for persons with hyperlipidemia. Dr. Ridker identifies those class of persons who would not benefit from statin treatment, and the practical utilization of the CRP tests.

    Brought to you by:

    NLA logo

     

Facebook Comments

Recommended
Details
Presenters
Comments
  • Overview

    According to a new study published in the New England Journal of Medicine, men and women who have normal cholesterol levels but signs of inflammation in the blood vessels (high levels of C-reactive protein) can cut the risk of heart attack or stroke in half.  Dr. Paul Ridker, author of the study, discusses the scope and findings of the study with host Dr. Larry Kaskel as well as the controversial implications of the study. Dr. Ridker explains the remarkable correlations between high-sensitivity C-reactive protein and cardiovascular disease, and reviews the number needed treat as compared with the use of statins for persons with hyperlipidemia. Dr. Ridker identifies those class of persons who would not benefit from statin treatment, and the practical utilization of the CRP tests.

    Brought to you by:

    NLA logo

     

Facebook Comments

Schedule23 Apr 2024